| scholarly article | Q13442814 |
| P2093 | author name string | Nakamura H | |
| Watanabe Y | |||
| Wakamatsu Y | |||
| Kondoh H | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 1953-1962 | |
| P577 | publication date | 1997-05-01 | |
| P1433 | published in | Development | Q3025404 |
| P1476 | title | Regulation of the neural crest cell fate by N-myc: promotion of ventral migration and neuronal differentiation | |
| P478 | volume | 124 |
| Q47296065 | Alternative NHEJ pathway proteins as components of MYCN oncogenic activity in human neural crest stem cell differentiation: implications for neuroblastoma initiation |
| Q36935686 | Anaplastic lymphoma kinase is dynamically expressed on subsets of motor neurons and in the peripheral nervous system |
| Q90642689 | CAMKV Is a Candidate Immunotherapeutic Target in MYCN Amplified Neuroblastoma |
| Q41827571 | Comprehensive spatiotemporal analysis of early chick neural crest network genes |
| Q90321088 | Enhanced expression of MycN/CIP2A drives neural crest toward a neural stem cell-like fate: Implications for priming of neuroblastoma |
| Q48146623 | Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma. |
| Q41659666 | Exploitation of chick embryo environments to reprogram MYCN-amplified neuroblastoma cells to a benign phenotype, lacking detectable MYCN expression |
| Q35723535 | Expression of MYCN in Multipotent Sympathoadrenal Progenitors Induces Proliferation and Neural Differentiation, but Is Not Sufficient for Tumorigenesis |
| Q30500159 | FGF8 signaling is chemotactic for cardiac neural crest cells |
| Q90066743 | FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma |
| Q33815657 | Functional promoter polymorphisms govern differential expression of HMG-CoA reductase gene in mouse models of essential hypertension |
| Q34723399 | Generation of murine sympathoadrenergic progenitor-like cells from embryonic stem cells and postnatal adrenal glands |
| Q38663502 | Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. |
| Q54110583 | Hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth. |
| Q36893712 | High Myc pathway activity and low stage of neuronal differentiation associate with poor outcome in neuroblastoma |
| Q34068218 | Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype |
| Q28509072 | Interplay of SOX and POU factors in regulation of the Nestin gene in neural primordial cells |
| Q37278519 | MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development |
| Q34066263 | Malignant progression and blockade of angiogenesis in a murine transgenic model of neuroblastoma |
| Q24294609 | Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes α-Tubulin Acetylation and Cell Differentiation |
| Q35905592 | MycN Is Critical for the Maintenance of Human Embryonic Stem Cell-Derived Neural Crest Stem Cells |
| Q43875587 | N-myc promotes survival and induces S-phase entry of postmitotic sympathetic neurons. |
| Q37201479 | Neuroblastoma and MYCN |
| Q45875651 | Neuroblastoma pathogenesis: deregulation of embryonic neural crest development |
| Q35564199 | Neuroblastoma: molecular pathogenesis and therapy |
| Q38130615 | New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK. |
| Q24676528 | Novel c-MYC target genes mediate differential effects on cell proliferation and migration |
| Q38448691 | Post-translational control of Myc function during differentiation |
| Q34162893 | Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma |
| Q39465676 | Primary culture of chick, mouse or human neural crest cells |
| Q36663011 | RTN4IP1 is down-regulated in thyroid cancer and has tumor-suppressive function |
| Q52728024 | Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cells. |
| Q39208675 | The MYCN Protein in Health and Disease |
| Q89842629 | The PLAGL2/MYCN/miR-506-3p interplay regulates neuroblastoma cell fate and associates with neuroblastoma progression |
| Q37836006 | The connections between neural crest development and neuroblastoma |
| Q33574489 | Ultrastructural features of neuroblastic tumours in relation to morphological, and molecular findings; a retrospective review study |
| Q33519157 | Upstream ORF affects MYCN translation depending on exon 1b alternative splicing |
| Q38826671 | WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma |
| Q37995064 | What is bad in cancer is good in the embryo: importance of EMT in neural crest development |
| Q64108352 | Wnt Signaling Is a Major Determinant of Neuroblastoma Cell Lineages |
| Q47148434 | cMyc Regulates the Size of the Premigratory Neural Crest Stem Cell Pool |
Search more.